Evidence map›Paper›PMID 42400257›Full record

ArticleGut microbes2026

Microbial metabolite Urolithin A protects against inorganic arsenic-induced gut barrier dysfunction in humanized

Sweta Ghosh, Zachary Matthew Vanwinkle, Kanchan Sinha Roy, Miroslav Stýblo, Mayukh Banerjee, James Collins, Venkatakrishna Rao Jala

Abstract read
In one paragraph

Article in Gut microbes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sweta GhoshDepartment of Microbiology and Immunology, Brown Cancer Center, Center for Microbiomics, Inflammation and Pathogenicity, Center for Integrative Environmental Health Sciences, University of Louisville, Louisville, KY, USA.ORCID 0000-0003-0613-8687
Zachary Matthew VanwinkleDepartment of Microbiology and Immunology, Brown Cancer Center, Center for Microbiomics, Inflammation and Pathogenicity, Center for Integrative Environmental Health Sciences, University of Louisville, Louisville, KY, USA.
Kanchan Sinha RoyDepartment of Microbiology and Immunology, Brown Cancer Center, Center for Microbiomics, Inflammation and Pathogenicity, Center for Integrative Environmental Health Sciences, University of Louisville, Louisville, KY, USA.ORCID 0000-0001-7726-6788
Miroslav StýbloDepartment of Nutrition, CB# 7461, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Mayukh BanerjeeDepartment of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, KY, USA.
James CollinsDepartment of Microbiology and Immunology, Center for Microbiomics, Inflammation and Pathogenicity, University of Louisville, Louisville, KY, USA.ORCID 0000-0003-2479-5189
Venkatakrishna Rao JalaDepartment of Microbiology and Immunology, Brown Cancer Center, Center for Microbiomics, Inflammation and Pathogenicity, Center for Integrative Environmental Health Sciences, University of Louisville, Louisville, KY, USA.ORCID 0000-0002-4206-7305

Funding

Understanding the Host-Microbiome-Therapeutic Triad: Implications for Designing Alternative IntravaginalP20GM125504 · NIGMS · UNIVERSITY OF LOUISVILLE · PI Shirin Ghods · 2018 to 2026
$24.4M
University of Louisville Center for Integrative Environmental Health SciencesP30ES030283 · NIEHS · UNIVERSITY OF LOUISVILLE · PI Amanda Jo LeBlanc · 2020 to 2026
$10.0M
AHR-NLRP6 interactions in gut barrier dysfunction and colitisR01DK135603 · NIDDK · UNIVERSITY OF LOUISVILLE · PI Venkatakrishna Rao Jala · 2024 to 2026
$1.6M
NIDDK NIH HHS R01 DK135603NIEHS NIH HHS P30 ES030283NIGMS NIH HHS P20 GM125504
6 · The paper itself

Abstract

Chronic exposure to inorganic arsenic (iAs) remains a major environmental health concern and is associated with significant gastrointestinal (GI) disorders, including gastroenteritis, diarrhea, and inflammatory bowel disease-like symptoms. Gut microbiota plays a critical role in mitigating arsenic toxicity, as germ-free or antibiotic-treated mice exhibit reduced fecal arsenic excretion and greater tissue accumulation. We previously showed that the microbial metabolite Urolithin A (UroA) protects against iAs-induced cytotoxicity, apoptosis, oxidative stress, and ROS production in vitro. In this study, using humanized

Indexed as

ArsenicCoumarinsGastrointestinal MicrobiomeMethyltransferasesProtective AgentsAnimalsBacteriaColonCytokinesHumansIntestinal Barrier FunctionIntestinal MucosaMiceMice, TransgenicTight Junction Proteins3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-oneArsenicCoumarinsCytokinesMethyltransferasesProtective AgentsTight Junction Proteinsgut barrier dysfunctionGut microbiotahAS3MT transgenic miceinorganic arsenic (iAs)intestinal inflammationUrolithin A (UroA)

Identifiers

PMID42400257
PMCPMC13348994

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.